SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...
Amsterdam – Rheumatoid arthritis patients who are on standard methotrexate therapy may benefit from the addition of the biologic treatment, ENBREL* (etanercept), according to new data from a one-year, ...
BURLINGTON, Mass.--(BUSINESS WIRE)-- Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer’s Enbrel ...
In Amgen’s latest campaign for Enbrel, kids are speaking up. Two new TV commercials feature children talking about their parents’ painful arthritis and their worries about it. The “Being There” ...
said Friday that Enbrel, its rheumatoid arthritis drug, is also effective in treating patients with psoriasis, according to results from a late-stage clinical study. Anyone surprised by these results ...
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...
Sofusa is a drug delivery platform technology which delivers biologic therapies through the skin directly into the lymphatic system with potential to improve efficacy and safety and reduce the ...
LONDON (Reuters) - A copy of the blockbuster biotech drug Enbrel was recommended for approval in Europe on Friday, making it the second so-called biosimilar antibody medicine to win such a green light ...
A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...
I'm one of 47,000 Medicare recipients lucky enough to receive a drug that my old rheumatologist, who originally prescribed it for me, described as a miracle. When he was a young doctor, he told me, ...
Amgen, the world’s biggest biotechnology company, won an appeals court ruling that prevents an Israeli company from seeking royalties on Enbrel, the rheumatoid arthritis treatment. Israel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback